NCT05382364 2026-03-12Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)PfizerPhase 1 Active not recruiting25 enrolled
NCT05892068 2026-02-13A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the BrainMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting9 enrolled
NCT04579380 2025-12-19Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsSeagen Inc.Phase 2 Active not recruiting217 enrolled 19 charts